NEJM: Release your inner health IT productivity

Rope - 66.34 Kb
A perspective article published in the June 14 edition of the New England Journal of Medicine set out to explain the “IT productivity paradox” and its relation to the rise of health IT implementations.

Spencer S. Jones, PhD, from Rand in Boston, and colleagues defined the paradox as the relationship between the rapid increase in IT use and the simultaneous slowdown in productivity. “There is ongoing debate about the wisdom of the $27 billion federal investment in driving the adoption of health IT under the HITECH Act,” Jones et al wrote.

Proponents expect IT to transform healthcare delivery into a lean, mean, integrated machine while skeptics suggest productivity benefits of health IT have been overhyped.

The authors noted that explanations for the IT productivity paradox fell into three categories: mismeasurement, mismanagement and poor useability. “Mismeasurement explanations traced the paradox to shortcomings in research; the latter two categories highlighted shortcomings in practice.”

In resolving the original IT productivity paradox, the mismeasurement challenge was addressed through a combination of detailed data and improved empirical techniques that better accounted for service outputs, the authors stated. “Similarly, assessment of the value of healthcare outputs could be improved through the more sophisticated use of clinical data to understand access, convenience and health outcomes. Such a measurement approach may prove far superior to simple counts of tests ordered or services delivered.”

“Healthcare professionals are tempted to simply digitize paper-based workflows, but swapping out the medical record cabinet and prescription pad for a computer is proving insufficient to realize the benefits of health IT,” the authors asserted. “Instead, newly IT-enabled processes that support teamwork, care coordination and innovative approaches such as interactive patient portals have the potential to yield greater convenience, access and quality for patients and physicians at a lower cost.”

According to the authors, new health IT systems risk failure if useability isn’t carefully addressed. User-centered design calls for end users to be involved in every stage of product development. Citing smartphones as an example, Jones and colleagues noted the merits of such design processes stating smartphones have come a long way from their early monochromatic displays to today’s high-definition touchscreens.

Maximizing the productivity of health IT will require that commercial IT vendors also adopt user-centered design principles, they added.

“In the meantime, avoiding broad claims about overall value that are based on limited evidence may permit a clearer focus on the best ways of optimizing IT’s use in healthcare,” they concluded.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.